« Demise of the world's most famous iceberg | Main | The sick and famous »

Another promising obesity drug bites the dust

Therapy failure highlights difficulties of tricking the body into shedding pounds.

Efforts to hold back the world's expanding waistline have been dealt another blow this week, as scientists announce disappointing results from a clinical trial of their latest obesity drug.

Read the story here.

Posted by Nicola Jones on October 03, 2006
Categories: | | Comments (1) | TrackBacks (0)

TrackBack

TrackBack URL for this entry:
http://blogs.nature.com/cgi-bin/mt/mt-tb.cgi/1257

Comments

MK-0546 seems to be an allagory of an alagorical other… MK-801 in cell culture as a glutamate-amide and resulting in α-ketoacid glycolysis form of the amino acid as an operon.

Posted by: mark brenneman | October 4, 2006 01:32 PM

Post a comment

Comments will be reviewed by staff before being published. You can be as critical or controversial as you like, but please don't get personal or offensive, and do keep it brief. Excessively long entries may be cropped. Remember this is for feedback and discussion - not for publishing papers or press releases.

We strongly encourage you to use your real, full name. Email addresses are required: this is just in case we need to discuss your comment with you privately. They won’t be published.


Please enter the numbers you see below - this helps us to cut down on spam. Note that attempting to post within 30 seconds of hitting ‘preview’ or ‘post’ can cause the system to think you are spamming the site. If you are having trouble with this system, you can instead e-mail a comment to 'inthefield at nature.com'.

Search